Marchex (MCHX)
(Delayed Data from NSDQ)
$1.37 USD
+0.03 (1.86%)
Updated Apr 24, 2024 03:59 PM ET
After-Market: $1.40 +0.03 (2.19%) 7:50 PM ET
2-Buy of 5 2
D Value A Growth F Momentum C VGM
Income Statements
Fiscal Year end for Marchex, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 50 | 52 | 53 | 51 | 106 |
Cost Of Goods | 21 | 20 | 22 | 21 | 57 |
Gross Profit | 29 | 32 | 32 | 30 | 50 |
Selling & Adminstrative & Depr. & Amort Expenses | 39 | 40 | 44 | 74 | 56 |
Income After Depreciation & Amortization | -10 | -8 | -12 | -44 | -7 |
Non-Operating Income | 0 | 0 | 8 | 0 | 1 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | -10 | -8 | -4 | -44 | -6 |
Income Taxes | 0 | 0 | 0 | -2 | -2 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -10 | -8 | -4 | -42 | -4 |
Extras & Discontinued Operations | 0 | 0 | 0 | 4 | 0 |
Net Income (GAAP) | -10 | -8 | -4 | -38 | -4 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -6 | -4 | -6 | -17 | 2 |
Depreciation & Amortization (Cash Flow) | 4 | 4 | 6 | 27 | 8 |
Income After Depreciation & Amortization | -10 | -8 | -12 | -44 | -7 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 47.28 | 43.39 | 48.58 | 50.92 | 45.46 |
Diluted EPS Before Non-Recurring Items | -0.18 | -0.14 | -0.18 | -0.36 | -0.01 |
Diluted Net EPS (GAAP) | -0.21 | -0.17 | -0.10 | -0.83 | -0.08 |
Fiscal Year end for Marchex, Inc falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 12.39 | 12.78 | 12.52 | 12.22 |
Cost Of Goods | NA | 4.68 | 5.06 | 5.42 | 5.42 |
Gross Profit | NA | 7.71 | 7.72 | 7.10 | 6.79 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 8.82 | 9.04 | 9.81 | 11.29 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -1.11 | -1.32 | -2.71 | -4.50 |
Non-Operating Income | NA | 0.02 | -0.22 | -0.03 | 0.06 |
Interest Expense | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | NA | -1.10 | -1.54 | -2.73 | -4.45 |
Income Taxes | NA | 0.04 | 0.01 | 0.01 | 0.03 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -1.14 | -1.55 | -2.74 | -4.48 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -1.14 | -1.55 | -2.74 | -4.48 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 47.38 | 47.43 | 47.16 | 40.69 |
Diluted EPS Before Non-Recurring Items | NA | -0.01 | -0.03 | -0.05 | -0.10 |
Diluted Net EPS (GAAP) | NA | -0.02 | -0.04 | -0.06 | -0.09 |